Abstract PO3-13-09: Personalized ctDNA testing for detection of molecular residual disease in patients with localized HR+ breast cancer: temporal dynamics and impact on clinical outcomesArielle J. Medford, Aditya Bardia, Rachel O. Abelman et al.|Cancer Research|2024Cited by 1